Navigation Links
Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents

.3 percent). However, somnolence, sedation and fatigue typically occurred early in the study and most resolved as treatment continued. The incidence of syncopal events was less than 1 percent. In some of the patients who did experience syncope, potential contributing factors were noted (such as dehydration, sudden change in body position, and hot environment). While small changes in average blood pressure and pulse rate occurred, cardiovascular events were uncommon.

For all doses, the mean ADHD-RS-IV total scores and subscale scores showed significant improvement from baseline to endpoint: -18.1 points on the ADHD- RS-IV total; -8.5 points on the ADHD-RS-IV hyperactive/impulsive subscale and -9.5 points on the ADHD-RS-IV inattentive subscale (P <.001).

Similar to the 303 study, the objective of the 305 open-label trial was to assess the long-term safety and efficacy of GXR for the treatment of ADHD in children and adolescents aged 6 to 17 years. During the first month of this study, investigators made weekly adjustments as needed to each participants' once-daily GXR doses from 1 mg to 4 mg for optimal dosing, as defined by 30 percent or more improvement in ADHD-RS-IV total scores.

In this trial, the most commonly reported treatment emergent adverse events greater than 10 percent were somnolence (29.9 percent), headache (19.7 percent), upper respiratory tract infection (15.1 percent), fatigue (12.4 percent) and sedation (11.2 percent). The incidence of syncopal events was less than 2 percent. As in the 303 open-label study, potential contributing factors were noted in some of the patients who did experience syncope. No clinically relevant trends in ECGs, hematologic or laboratory parameters, vital signs, urinalyses, or physical examination were seen.

Interim results from trial 305 showed that for all doses, the mean ADHD- RS-IV total scores showed significant improvement of -21.6 points from baseline to endpoint (P <.001).

About Gua
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/29/2014)... 2014 Research and Markets has ... Therapeutics Market & Pipeline Insight 2014" report to ... to prevent and eradicate the prevalence of cancer have ... confined to low specificity, safety and large number of ... a better solution. It has been discovered that peptides ...
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... Where do you start when trying to minimize the ... independent nonprofit that researches the best approaches to improving patient ... its 5th annual list of Top 10 Health Technology ... download with registration, the list features the top 10 ...
... Dec. 7, 2010 Millennium Research Group (MRG), the ... release their latest data on the US clot management ... for Clot Management Devices 2011 report provides important ... and the complex competitive dynamics of medical device manufacturers ...
Cached Medicine Technology:ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 2ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 3Millennium Research Group to Release Their Latest US Clot Management Data 2
(Date:8/29/2014)... As reported by CNN.com in the article ... process of admitting that you need help for a prescription ... and highlights the fact that if you simply try to ... overwhelmed by all of the information that is available online. ... through, it is still possible to get help. The statistics ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to new ... But Not Peer Pressure, Key to Prescription Drug Misuse Among ... primary focus for 18-29 year olds when it comes to ... the for this age group the real problem which influences ... drug associations and recreational use of them to have fun ...
(Date:8/29/2014)... article entitled How Genes, Gender and Environment Influence Substance ... gender and the environment that an individual is in affect ... Indiana University are taking another look at the fact that ... this factor to what is known about the influences of ... ties can help to reduce a man’s risk for abusing ...
(Date:8/29/2014)... 29, 2014 Formed in 2014, KAJ Brothers ... beyond their years. Their sophisticated Pop/R&B sound, with beautiful ... is fortunate enough to experience every day. , ... uplifted and feeling loved with the primary purpose of elevating ... this, the group unanimously replied - “To make chivalry cool ...
(Date:8/29/2014)... Mirada, CA (PRWEB) August 29, 2014 ... which will give patients the convenience of visiting ... with Healthpointe doctors through telemedicine. , Healthpointe doctors are ... calls (or audio). If necessary, the doctor can even ... assessed the patient’s condition, he or she can prescribe ...
Breaking Medicine News(10 mins):Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 2Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2
... WASHINGTON, June 4 Walgreen Co. of,Deerfield, Ill., ... claims that from,2001 to 2005, it improperly switched ... Fluoxetine and Eldepryl in order to,increase its reimbursement ... which operates over 5,000 retail pharmacies throughout the,U.S., ...
... TORONTO, June 4 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... appeal the,recent decision made by American Stock Exchange (the ... appeal determination process, the,Company,s stock will continue to trade ... to trade on the Toronto Stock Exchange (the "TSX"),under ...
... patients who lose nerve signals , , WEDNESDAY, June 4 ... improved after receiving human neural stem cell transplants, a ... substance that plays a critical role in the transmission ... missing or damaged, electrical signals aren,t properly transmitted. These ...
... (48%) of high,school teens say they have had sex--an increase ... by the Centers for Disease Control,and Prevention. During the same ... used a condom the last time they had sex decreased ... Youth Risk Behavior Surveillance,System. The survey is administered every two ...
... A failed drug launch can cost,a pharmaceutical ... end,up costing a company more. Leading pharmaceutical companies ... sales with a re-launch, according to a,study by ... As best-in-class pharma companies have demonstrated, combining ...
... Two members of Easter Seals national,corporate partner family -- ... across the Chicagoland area to bring value to consumers, ... consumers visiting any Chicagoland CENTURY,21(R) office or open house ... or transferred prescription is brought to CVS/pharmacy for use ...
Cached Medicine News:Health News:Walgreens to Pay $35 Million to U.S., 46 States & Puerto Rico to Settle Medicaid Prescription Drug Fraud Allegations 2Health News:PreMD Appeals American Stock Exchange Delisting Notification 2Health News:Human Stem Cell Transplant Helps Brain-Impaired Mice 2Health News:Teen Sexual Activity Increases, Contraceptive Use Decreases 2Health News:Redefining a Product's Identity Key to a Successful Re-Launch 2Health News:CVS/pharmacy and CENTURY 21(R) Team Up With Easter Seals Around Chicagoland 2
Coude Foley Catheters (Latex) 2-Way Amber...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Silicone Foley Catheters 3-Way...
Midstream Catch Kits...
Medicine Products: